What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
His main research concerns Cancer, Internal medicine, DNA repair, Cancer research and Breast cancer.
His Cancer research is multidisciplinary, incorporating perspectives in Missense mutation, Antibiotics, Hereditary diffuse gastric cancer, Genetic counseling and Genetic testing.
The concepts of his Internal medicine study are interwoven with issues in Pharmacogenetics and Oncology.
His biological study spans a wide range of topics, including Mutation and Molecular biology.
His Cancer research study combines topics from a wide range of disciplines, such as Gene expression profiling, Carcinogenesis, Metastatic breast cancer, Single-cell analysis and Metastasis.
His studies deal with areas such as Epithelial–mesenchymal transition, Germline mutation, Circulating tumor cell and Pathology as well as Breast cancer.
His most cited work include:
- Pharmacology of drugs that alter multidrug resistance in cancer. (903 citations)
- American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility (584 citations)
- Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair (525 citations)
What are the main themes of his work throughout his whole career to date?
Internal medicine, Oncology, Cancer, Breast cancer and Cancer research are his primary areas of study.
His research on Internal medicine frequently connects to adjacent areas such as Pathology.
While the research belongs to areas of Oncology, James M. Ford spends his time largely on the problem of Iniparib, intersecting his research to questions surrounding Neoadjuvant therapy.
James M. Ford has researched Cancer in several fields, including Genetic counseling and Hereditary diffuse gastric cancer.
As part of one scientific family, James M. Ford deals mainly with the area of Breast cancer, narrowing it down to issues related to the Gemcitabine, and often Cisplatin.
James M. Ford focuses mostly in the field of Cancer research, narrowing it down to matters related to DNA repair and, in some cases, Molecular biology and Genome instability.
He most often published in these fields:
- Internal medicine (42.26%)
- Oncology (34.38%)
- Cancer (30.71%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (42.26%)
- Oncology (34.38%)
- Cancer (30.71%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Internal medicine, Oncology, Cancer, Cancer research and Breast cancer.
His work in Internal medicine covers topics such as Multiplex which are related to areas like Cancer screening and Prospective cohort study.
James M. Ford combines subjects such as Medical record, Microarray, Cancer registry, Stage and Colorectal cancer with his study of Oncology.
His Cancer research is multidisciplinary, relying on both Computational biology, Gene and Genetic testing.
His Cancer research research also works with subjects such as
- PARP inhibitor which is related to area like Talazoparib,
- DNA damage which is related to area like DNA repair and Cancer cell.
The study incorporates disciplines such as Mutation, Ovarian cancer and Chemotherapy in addition to Breast cancer.
Between 2016 and 2021, his most popular works were:
- Long-read genome sequencing identifies causal structural variation in a Mendelian disease (113 citations)
- NCCN guidelines® insights: Genetic/Familial High-Risk Assessment: Colorectal, version 3.2017 featured updates to the NCCN Guidelines (111 citations)
- The Human Tumor Atlas Network: Charting Tumor Transitions Across Space and Time at Single-Cell Resolution (65 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
His primary scientific interests are in Cancer, Cancer research, Internal medicine, Breast cancer and Oncology.
His research in Cancer intersects with topics in Precision medicine, Germline mutation, Personalized medicine and Genetic testing.
His research integrates issues of DNA damage, PARP inhibitor, Cancer cell, Pathology and In vivo in his study of Cancer research.
James M. Ford studies Medical record, a branch of Internal medicine.
His Breast cancer research focuses on Mutation and how it connects with Germline, Mutant, Homologous recombination, Taxane and Chemotherapy.
His study in Oncology is interdisciplinary in nature, drawing from both Anthracycline, Cyclophosphamide, Doxorubicin, Cancer registry and Triple-negative breast cancer.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
